State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT06602271 Phase 3
Recruiting
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Condition
Postoperative Pain, Acute
Enrollment
320 pts
Location
United States
Sponsor
Ensysce Biosciences
NCT06824064 Phase 2
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Col...
Condition
Metastatic Colorectal Cancer
Enrollment
150 pts
Location
United States, Vietnam
Sponsor
Riboscience, LLC.
NCT06212557 N/A
Recruiting
KIOS Mobile App Evaluation
Condition
Opioid Use Disorder
Enrollment
210 pts
Location
United States
Sponsor
The University of Texas Health
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT06163391 Phase 1
Recruiting
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metast...
Condition
Advanced Solid Tumor
Enrollment
40 pts
Location
United States, Belgium, Czechia
Sponsor
SOTIO Biotech AG
NCT03897374 N/A
Recruiting
Strategic Targeting for Optimal Prevention of Cancer
Condition
Early Detection of Cancer
Enrollment
120,000 pts
Location
United States
Sponsor
ClinLogic LLC
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05908123 N/A
Recruiting
Exploring the Nature, Assessment and Treatment of Stuttering
Condition
Stuttering
Enrollment
3,000 pts
Location
United States
Sponsor
University of Texas at Austin
NCT03114462 Phase 1
Recruiting
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryng...
Condition
Malignant Neoplasms of Respiratory and Intrathoracic Organs
Enrollment
11 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06704269 Phase 1, Phase 2
Recruiting
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized...
Condition
Generalized Myasthenia Gravis
Enrollment
15 pts
Location
United States, France, Japan
Sponsor
Novartis Pharmaceuticals
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT05275335 N/A
Recruiting
Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to...
Condition
Microbial Colonization
Enrollment
400 pts
Location
United States
Sponsor
The University of Texas Medica
NCT06447168 N/A
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in P...
Condition
Primary Biliary Cholangitis
Enrollment
424 pts
Location
United States, Austria, Canada
Sponsor
Ipsen
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT03471260 Phase 1, Phase 2
Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With ...
Condition
Acute Myeloid Leukemia
Enrollment
96 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT05064280 Phase 2
Recruiting
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With ...
Condition
Brain Metastases
Enrollment
104 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04715958 Phase 2, Phase 3
Recruiting
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasou...
Condition
Anatomic Stage III Breast Cancer AJCC v8
Enrollment
200 pts
Location
United States
Sponsor
Kibo Nam
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
NCT06817889 Phase 2
Recruiting
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in ...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation